79 related articles for article (PubMed ID: 38519058)
21. Multiplex digital spatial profiling of proteins and RNA in fixed tissue.
Merritt CR; Ong GT; Church SE; Barker K; Danaher P; Geiss G; Hoang M; Jung J; Liang Y; McKay-Fleisch J; Nguyen K; Norgaard Z; Sorg K; Sprague I; Warren C; Warren S; Webster PJ; Zhou Z; Zollinger DR; Dunaway DL; Mills GB; Beechem JM
Nat Biotechnol; 2020 May; 38(5):586-599. PubMed ID: 32393914
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin Analogs in Clinical Practice: a Review.
Gomes-Porras M; Cárdenas-Salas J; Álvarez-Escolá C
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121432
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment.
Helms E; Onate MK; Sherman MH
Cancer Discov; 2020 May; 10(5):648-656. PubMed ID: 32014869
[TBL] [Abstract][Full Text] [Related]
24. B cells and tertiary lymphoid structures promote immunotherapy response.
Helmink BA; Reddy SM; Gao J; Zhang S; Basar R; Thakur R; Yizhak K; Sade-Feldman M; Blando J; Han G; Gopalakrishnan V; Xi Y; Zhao H; Amaria RN; Tawbi HA; Cogdill AP; Liu W; LeBleu VS; Kugeratski FG; Patel S; Davies MA; Hwu P; Lee JE; Gershenwald JE; Lucci A; Arora R; Woodman S; Keung EZ; Gaudreau PO; Reuben A; Spencer CN; Burton EM; Haydu LE; Lazar AJ; Zapassodi R; Hudgens CW; Ledesma DA; Ong S; Bailey M; Warren S; Rao D; Krijgsman O; Rozeman EA; Peeper D; Blank CU; Schumacher TN; Butterfield LH; Zelazowska MA; McBride KM; Kalluri R; Allison J; Petitprez F; Fridman WH; Sautès-Fridman C; Hacohen N; Rezvani K; Sharma P; Tetzlaff MT; Wang L; Wargo JA
Nature; 2020 Jan; 577(7791):549-555. PubMed ID: 31942075
[TBL] [Abstract][Full Text] [Related]
25. Desmoplastic melanoma: The role of pure and mixed subtype in sentinel lymph node biopsy and survival.
Laeijendecker AE; El Sharouni MA; Sigurdsson V; van Diest PJ
Cancer Med; 2020 Jan; 9(2):671-677. PubMed ID: 31804771
[TBL] [Abstract][Full Text] [Related]
26. Tumor-associated macrophages: an accomplice in solid tumor progression.
Chen Y; Song Y; Du W; Gong L; Chang H; Zou Z
J Biomed Sci; 2019 Oct; 26(1):78. PubMed ID: 31629410
[TBL] [Abstract][Full Text] [Related]
27. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.
Monteran L; Erez N
Front Immunol; 2019; 10():1835. PubMed ID: 31428105
[TBL] [Abstract][Full Text] [Related]
28. High-Plex Predictive Marker Discovery for Melanoma Immunotherapy-Treated Patients Using Digital Spatial Profiling.
Toki MI; Merritt CR; Wong PF; Smithy JW; Kluger HM; Syrigos KN; Ong GT; Warren SE; Beechem JM; Rimm DL
Clin Cancer Res; 2019 Sep; 25(18):5503-5512. PubMed ID: 31189645
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis.
Fu Q; Chen N; Ge C; Li R; Li Z; Zeng B; Li C; Wang Y; Xue Y; Song X; Li H; Li G
Oncoimmunology; 2019; 8(7):1593806. PubMed ID: 31143514
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial.
Lebbé C; Meyer N; Mortier L; Marquez-Rodas I; Robert C; Rutkowski P; Menzies AM; Eigentler T; Ascierto PA; Smylie M; Schadendorf D; Ajaz M; Svane IM; Gonzalez R; Rollin L; Lord-Bessen J; Saci A; Grigoryeva E; Pigozzo J
J Clin Oncol; 2019 Apr; 37(11):867-875. PubMed ID: 30811280
[TBL] [Abstract][Full Text] [Related]
31. Desmoplastic melanoma: a brief review and the efficacy of immunotherapy.
Ochoa CE; Joseph RW
Expert Rev Anticancer Ther; 2019 Mar; 19(3):205-207. PubMed ID: 30686076
[No Abstract] [Full Text] [Related]
32. Desmoplastic melanoma.
Nicolson NG; Han D
J Surg Oncol; 2019 Jan; 119(2):208-215. PubMed ID: 30481377
[TBL] [Abstract][Full Text] [Related]
33. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S
Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061
[TBL] [Abstract][Full Text] [Related]
34. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial.
Hodi FS; Chiarion-Sileni V; Gonzalez R; Grob JJ; Rutkowski P; Cowey CL; Lao CD; Schadendorf D; Wagstaff J; Dummer R; Ferrucci PF; Smylie M; Hill A; Hogg D; Marquez-Rodas I; Jiang J; Rizzo J; Larkin J; Wolchok JD
Lancet Oncol; 2018 Nov; 19(11):1480-1492. PubMed ID: 30361170
[TBL] [Abstract][Full Text] [Related]
35. Nano-delivery of fraxinellone remodels tumor microenvironment and facilitates therapeutic vaccination in desmoplastic melanoma.
Hou L; Liu Q; Shen L; Liu Y; Zhang X; Chen F; Huang L
Theranostics; 2018; 8(14):3781-3796. PubMed ID: 30083259
[No Abstract] [Full Text] [Related]
36. Lymphoid aggregates in desmoplastic melanoma have features of tertiary lymphoid structures.
Stowman AM; Hickman AW; Mauldin IS; Mahmutovic A; Gru AA; Slingluff CL
Melanoma Res; 2018 Jun; 28(3):237-245. PubMed ID: 29538091
[TBL] [Abstract][Full Text] [Related]
37. High response rate to PD-1 blockade in desmoplastic melanomas.
Eroglu Z; Zaretsky JM; Hu-Lieskovan S; Kim DW; Algazi A; Johnson DB; Liniker E; Ben Kong ; Munhoz R; Rapisuwon S; Gherardini PF; Chmielowski B; Wang X; Shintaku IP; Wei C; Sosman JA; Joseph RW; Postow MA; Carlino MS; Hwu WJ; Scolyer RA; Messina J; Cochran AJ; Long GV; Ribas A
Nature; 2018 Jan; 553(7688):347-350. PubMed ID: 29320474
[TBL] [Abstract][Full Text] [Related]
38. Melanoma subtypes demonstrate distinct PD-L1 expression profiles.
Kaunitz GJ; Cottrell TR; Lilo M; Muthappan V; Esandrio J; Berry S; Xu H; Ogurtsova A; Anders RA; Fischer AH; Kraft S; Gerstenblith MR; Thompson CL; Honda K; Cuda JD; Eberhart CG; Handa JT; Lipson EJ; Taube JM
Lab Invest; 2017 Sep; 97(9):1063-1071. PubMed ID: 28737763
[TBL] [Abstract][Full Text] [Related]
39. M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma.
Falleni M; Savi F; Tosi D; Agape E; Cerri A; Moneghini L; Bulfamante GP
Melanoma Res; 2017 Jun; 27(3):200-210. PubMed ID: 28272106
[TBL] [Abstract][Full Text] [Related]
40. Tumoral PD-L1 expression in desmoplastic melanoma is associated with depth of invasion, tumor-infiltrating CD8 cytotoxic lymphocytes and the mixed cytomorphological variant.
Frydenlund N; Leone D; Yang S; Hoang MP; Deng A; Hernandez-Perez M; Singh R; Biswas A; Yaar R; Mahalingam M
Mod Pathol; 2017 Mar; 30(3):357-369. PubMed ID: 28084337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]